RxE2 Inc.

New Filing
CIK: 0001855833·Other·DELAWARE·Filed: Apr 8, 2021
Total Offering

$1

Amount Sold

$1

Investors

4

First Sale

Mar 10, 2021

Offering Details

Type
Other: common stock upon conversion
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2021
Non-Accredited Investors
No

Related Persons

NameRole
Gerald Finken
Related Person

Company

RxE2 Inc.

4302 13TH AVE S, STE. 4326

FARGO, ND, 58103

701-361-7650

SEC Filing

0001855833-21-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
RxE2 Inc. Form D Filing — $1 | FilingFlow